Metabolic impact of combined hormonal contraceptives containing estradiol
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Is the replacement of ethinyl-estradiol (EE) with estradiol (E2) in combined hormonal contraceptives (CHCs) associated with fewer metabolic effects, leading to a further improvement on safety of hormonal contraceptives? AREAS COVERED: This is a narrative review paper including all available data on the metabolic impact of CHCs containing E2 published in English up to December 2015. Modification of a metabolic variable of interest during the first months of treatment was considered as an outcome. EXPERT OPINION: E2 was extensively used in oral contraceptives associated to nomegestrol acetate (NOMAc) in a monophasic 24 + 4 or its ester E2 valerate to dienogest (DNG) in a quadriphasic 26 + 2 regimen. The impact on the lipid metabolism and the hemostatic system of these preparations seems milder than that caused by EE-based ones, associated with no change of blood pressure. The impact on bone metabolism was instead similar to EE. Data available in the literature are mainly derived from studies having secondary minor metabolic outcomes as the primary end-point, and so currently not completely applicable on the real variables of interest (arterial or venous cardiovascular events, bone fractures). The preliminar parenteral use of E2 seems promising, both transdermal and vaginal, in particular after the introduction of a specific progestin with a high anti-ovulatory activity, like nestorone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Medical eligibility criteria for contraceptive use
Trussell, J. (2011) · Human Fertility · doi:10.3109/14647273.2011.602520 · Cited by 482
Lee, A. J., Cai, M. X., Thomas, P. E., Conney, A. H., & Zhu, B. T. (2003) · Endocrinology · doi:10.1210/en.2003-0192 · Cited by 456
Combined oral contraceptives: venous thrombosis
de Bastos, M., Stegeman, B. H., Rosendaal, F. R., Van Hylckama Vlieg, A., Helmerhorst, F. M., Stijnen, T., & Dekkers, O. M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010813.pub2 · Cited by 399
Oral contraceptives and venous thromboembolism: a five-year national case-control study☆
Lidegaard, Ø., Edström, B., & Kreiner, S. (2002) · Contraception · doi:10.1016/s0010-7824(01)00307-9 · Cited by 334
Insulin resistance, secretion, and metabolism in users of oral contraceptives
Godsland, I. F. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.1.64 · Cited by 251
Oelkers, W. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.6.1816 · Cited by 246
Hannaford, P. C., Iversen, L., Macfarlane, T. V., Elliott, A. M., Angus, V., & Lee, A. J. (2010) · BMJ · doi:10.1136/bmj.c927 · Cited by 243
Nestorone®: a progestin with a unique pharmacological profile
Kumar, N. (2000) · Steroids · doi:10.1016/s0039-128x(00)00119-7 · Cited by 184
SOME EFFECTS OF ORAL CONTRACEPTIVES ON SERUM-LIPID AND LIPOPROTEIN LEVELS
Wynn, V., Doar, J. W. H., & Mills, G. L. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92979-5 · Cited by 179
Blood Pressure in Women Taking Oral Contraceptives
Weir, R. J., Briggs, E., Mack, A., Naismith, L., Taylor, L., & Wilson, E. (1974) · BMJ · doi:10.1136/bmj.1.5907.533 · Cited by 164
Research works printed but not linked: 7
- Oelkers W, 1995, J Clin Endocrinol Metab, 80, 1816
- Lopez LM, 2014, Cochrane Database Syst Rev, 4, CD006133
- Godsland IF, 1992, J Clin Endocrinol Metab, 74, 64
- Lindberg UB, 1989, Thromb Haemost, 6, 65
- Commitee for medicinal products for human use (CHMP). Guideline on clinical investigation of steroid contraceptives in women
- 10.2165/11591200-000000000-00000 · doi:10.2165/11591200-000000000-00000 · Paper page
- Gambacciani M, 1994, Obstet Gynecol, 83, 392
Cited by
Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
“The recent development of two COCs containing natural estrogen (17-estradiol and 17-estradiol valerate) could be a valid therapeutic alternative in PCOS, showing a more favorable effect on metabolic profile, RAAS induction, and hemostatic balance compared with ethinyl estradiol [70,71].”
BackgroundEndocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone
Klipping, C., Duijkers, I., Mawet, M., Maillard, C., Bastidas, A., Jost, M., & Foidart, J.-M. (2021) · Contraception · doi:10.1016/j.contraception.2021.01.001 · Cited by 108
Reed, S., Koro, C. E., DiBello, J. R., Becker, K., Bauerfeind, A., Franke, C., & Heinemann, K. (2021) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2021.1987410 · Cited by 88
Mihajlovic, J., Leutner, M., Hausmann, B., Köhl, G., Schwarz, J., Röver, H., Stimakovits, N. M., Wolf, P. S., Maruszczak, K., Bastian, M., et al. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15517 · Cited by 62
Douxfils, J., Morimont, L., & Bouvy, C. (2020) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0040-1714140 · Cited by 48
Metadata
- Authors
- Grandi, G., Napolitano, A., & Cagnacci, A.
- Affiliations
- Azienda Ospedaliero-Universitaria di Modena (IT)
- Corresponding author
- Grandi, Giovanni
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2016-06
- Volume
- 12
- Issue
- 7
- Pages
- 779-787
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2399358581
- Cited by
- 50
- References
- 71
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 11 · 2022: 5 · 2021: 7 · 2020: 6 · 2019: 3 · 2018: 1 · 2017: 3
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by
- Locations
- Expert Opinion on Drug Metabolism & Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- estradiol, ethinyl estradiol, combined hormonal contraceptives, oral contraceptives, nomegestrol acetate, estradiol valerate, dienogest, lipid metabolism, hemostasis, blood pressure, bone metabolism, cardiovascular events, bone fractures, transdermal estradiol, vaginal estradiol, Nestorone, progestins
- MeSH terms
- Blood Pressure, Contraceptives, Oral, Combined, Contraceptives, Oral, Hormonal, Estradiol, Ethinyl Estradiol, Hemostasis, Humans, Megestrol, Nandrolone, Norpregnadienes, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic impact of combined hormonal contraceptives containing estradiol. https://app.cochat.ai/papers/10.1080/17425255.2016.1190832
- The paper
- Grandi, G., Napolitano, A., & Cagnacci, A. (2016). Metabolic impact of combined hormonal contraceptives containing estradiol. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2016.1190832
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.